Next Article in Journal
Anticancer Effect of Icaritin on Prostate Cancer via Regulating Abundance of Akkermansiaceae and Vitamin K2 in Intestinal Fecal
Next Article in Special Issue
Comment on Santana-Bejarano et al. NRP1 and GFAP Expression in the Medulloblastoma Microenvironment: Implications for Angiogenesis and Tumor Progression. Cancers 2025, 17, 2417
Previous Article in Journal
Robotic Vessel Sealer vs. Robotic Bipolar Grasper in Partial Nephrectomy
Previous Article in Special Issue
Comment on Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”

University Côte d’Azur, Institute for Research on Cancer and Ageing of Nice (IRCAN, UMR CNRS 7284/U INSERM 1081), 06100 Nice, France
*
Author to whom correspondence should be addressed.
Cancers 2026, 18(5), 803; https://doi.org/10.3390/cancers18050803
Submission received: 17 December 2025 / Accepted: 21 January 2026 / Published: 2 March 2026
(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Malignant Nervous System Cancers)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We gratefully thank R [...]

Share and Cite

MDPI and ACS Style

Karaulic, A.; Fournier, C.; Pagès, G. Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”. Cancers 2026, 18, 803. https://doi.org/10.3390/cancers18050803

AMA Style

Karaulic A, Fournier C, Pagès G. Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”. Cancers. 2026; 18(5):803. https://doi.org/10.3390/cancers18050803

Chicago/Turabian Style

Karaulic, Arthur, Clémence Fournier, and Gilles Pagès. 2026. "Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”" Cancers 18, no. 5: 803. https://doi.org/10.3390/cancers18050803

APA Style

Karaulic, A., Fournier, C., & Pagès, G. (2026). Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”. Cancers, 18(5), 803. https://doi.org/10.3390/cancers18050803

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop